Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gauri Rao

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Hepatology|December 21, 2017
Profile of extrahepatic portal venous obstruction among children in Central IndiaMayank Jain, Jenisha Jain, Gauri Rao Passi, et al.
Journal of Visualized Experiments : Jove|April 18, 2022
Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics StudySara Oberrauch, Jing Lu, Linda Cornthwaite-Duncan, et al.
International Journal of Antimicrobial Agents|October 19, 2020
Treatment of infections caused by Gram-negative pathogens: current status on the pharmacokinetics/pharmacodynamics of parenteral and inhaled polymyxins in patientsYu-Wei Lin, Su Mon Aye, Gauri Rao, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Pharmacodynamic variability beyond that explained by MICsRachel L Soon, Neang S Ly, Gauri Rao, et al.
Journal of the American Pharmacists Association : Japha|March 18, 2009
Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration modelScott V Monte, Erin M Slazak, Nicole Paolini Albanese, et al.
Antimicrobial Agents and Chemotherapy|January 26, 2026
A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant <i>Achromobacter xylosoxidans</i>Bhavatharini Arun, Rajnikant Sharma, Quentin Vallé, et al.
Clinical and Translational Science|November 7, 2021
Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID-19 pandemicJing Zhu, Gauri Rao, Paul M Armistead, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Antimicrobial Activity of <i>Lacticaseibacillus rhamnosus</i> CRL 2244 Extracts Against Community- and Hospital-Acquired <i>Staphylococcus aureus</i>Cecilia Rodriguez, Briea Gasca, Vyanka Mezcord, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 7, 2013
Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophreniaVidya Perera, Annette S Gross, Thomas M Polasek, et al.
Journal of Pharmaceutical Sciences|October 3, 2009
Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeuticsGauri Rao, Vandana Iyer, Matthew P Kosloski, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Hepatology|December 21, 2017
Profile of extrahepatic portal venous obstruction among children in Central IndiaMayank Jain, Jenisha Jain, Gauri Rao Passi, et al.
Journal of Visualized Experiments : Jove|April 18, 2022
Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics StudySara Oberrauch, Jing Lu, Linda Cornthwaite-Duncan, et al.
International Journal of Antimicrobial Agents|October 19, 2020
Treatment of infections caused by Gram-negative pathogens: current status on the pharmacokinetics/pharmacodynamics of parenteral and inhaled polymyxins in patientsYu-Wei Lin, Su Mon Aye, Gauri Rao, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Pharmacodynamic variability beyond that explained by MICsRachel L Soon, Neang S Ly, Gauri Rao, et al.
Journal of the American Pharmacists Association : Japha|March 18, 2009
Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration modelScott V Monte, Erin M Slazak, Nicole Paolini Albanese, et al.
Antimicrobial Agents and Chemotherapy|January 26, 2026
A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant <i>Achromobacter xylosoxidans</i>Bhavatharini Arun, Rajnikant Sharma, Quentin Vallé, et al.
Clinical and Translational Science|November 7, 2021
Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID-19 pandemicJing Zhu, Gauri Rao, Paul M Armistead, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Antimicrobial Activity of <i>Lacticaseibacillus rhamnosus</i> CRL 2244 Extracts Against Community- and Hospital-Acquired <i>Staphylococcus aureus</i>Cecilia Rodriguez, Briea Gasca, Vyanka Mezcord, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 7, 2013
Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophreniaVidya Perera, Annette S Gross, Thomas M Polasek, et al.
Journal of Pharmaceutical Sciences|October 3, 2009
Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeuticsGauri Rao, Vandana Iyer, Matthew P Kosloski, et al.
Pageof 4